Home arrow Products >> arrow CaloMist™
CaloMist™ Print E-mail

calomist calomist_pantone













New once-daily CaloMist™ is the sting-free alternative to painful intramuscular B12 therapy.

• Maintains consistent serum B12 levels.(1*)
• Effectiveness of intramuscular therapy — without the pain of injection (1*)
• Convenient, once-daily dosing
• Easy-to-use nasal spray

• Easy-to-remember dosing schedule — fits into your daily routine
• Safe, well tolerated, and preferred by patients (1*, 2)

Why does CaloMist™ represent a new era in B12 therapy?
It’s the only daily nasal spray that provides the effectiveness of intramuscular therapy
without the inconvenience and pain.


Click here to view the complete Prescribing Information.

How can you get new CaloMist™?
CaloMist™ is available with a doctor’s prescription through your local pharmacist.

 

For more information, please visit www.calomist.com or call 1.800.343.0164.      


Important Safety Information:
CaloMist™ (cyanocobalamin, USP) is indicated for the maintenance of vitamin B12 concentrations after normalization with intramuscular vitamin B12 therapy in patients with B12 deficiency who have no nervous system involvement. CaloMist™ is contraindicated in patients with sensitivity to cobalt, vitamin B12, or any component of the medication. Vitamin B12 concentrations must be monitored. Patients with declining or abnormally low vitamin B12 concentrations should be switched back to intramuscular vitamin B12 injections. Effectiveness in patients with nasal pathology or with other concomitant nasal drugs has not been determined. Cyanocobalamin causes optic nerve atrophy in patients with Leber’s disease; do not use this product in these patients. Anaphylaxis and angioedema have been reported with parenteral vitamin B12 products. The most common side effects of CaloMist™ are arthralgia, bronchitis, dizziness, headache, nasal discomfort, nasopharyngitis, rash, and rhinorrhea.


Manufactured by Fleming Pharmaceuticals, St. Louis County, MO. CaloMist is a trademark of Fleming Pharmaceuticals.



REFERENCES PAGE



©2008 Fleming Pharmaceuticals   All rights reserved   CM7119   January 2008 W079   Rev 1207